VANGUARD GROUP INC - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 82 filers reported holding DICE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 1.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$90,941,594
+64.6%
1,957,417
+1.5%
0.00%
+100.0%
Q1 2023$55,244,534
-7.0%
1,928,256
+1.3%
0.00%
-50.0%
Q4 2022$59,386,578
+111.2%
1,903,416
+37.3%
0.00%
+100.0%
Q3 2022$28,123,000
+49.0%
1,386,758
+14.0%
0.00%0.0%
Q2 2022$18,874,000
+65.4%
1,216,109
+103.8%
0.00%
Q1 2022$11,413,000
-22.6%
596,633
+2.5%
0.00%
Q4 2021$14,739,000582,3200.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders